Northwind Pharmaceuticals LLC recalls BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indian
Recalled May 3, 2023 · FDA recall D-0549-2023 · Northwind Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
6 bottles
Sold at
Nationwide with the United States
Description
CGMP Deviations
Product
BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-511-52
Manufacturer(s)
Northwind Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →